Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Pediatr Blood Cancer. 2021 Apr 21;68(9):e29065. doi: 10.1002/pbc.29065

TABLE 1.

Characteristics of eligible patients (N=30)

Characteristic Number (%)
Median age (range), years 9.5 (2 – 20)
Sex
 Male 21 (70)
 Female 9 (30)
Race
 White 20 (67)
 Black or African American 3 (10)
 Asian 1 (3)
 Multiple 1 (3)
 Unknown 5 (17)
Ethnicity
 Non-Hispanic 23 (77)
 Hispanic 5 (17)
 Unknown 2 (7)
Diagnosis (N=30)
 Brain Tumor (N=18)
  Choroid plexus carcinoma 1 (3)
  Ependymoma 4 (13)
  High-grade glioma 8 (27)
  Medulloblastoma 1 (3)
  Oligodendroglioma 1 (3)
  Pineoblastoma 1 (3)
  Primitive neuroectodermal tumor (PNET) 2 (7)
 Solid Tumor (N=12)
  Adenocarcinoma 1 (3)
  Ewing sarcoma 1 (3)
  Hepatocellular carcinoma 1 (3)
  Neuroendocrine carcinoma 1 (3)
  Osteosarcoma 2 (7)
  Rhabdomyosarcoma 4 (13)
  Undifferentiated sarcoma 1 (3)
  Wilms Tumor 1 (3)
Prior Therapy
 Median prior chemotherapy regimens (range) (N=29) 2 (1 – 8)
 Median prior radiation courses (range) (N=24) 1 (1 – 3)